EBM Newsdesk Analysis
May 15, 2026 — The FTSE 100 slid on Friday as the Trump-Xi summit produced what diplomats are privately calling “warm words and zero outcomes,” leaving the Iran conflict unresolved, oil above $107 a barrel, and US-China trade relations no clearer than they were on Monday. Sterling weakened to $1.33 — the lowest level in over a month — and UK 10-year gilt yields climbed back above 5.1 percent as Andy Burnham‘s declared bid to enter Downing Street via a by-election added another layer of political instability to a country that has now changed prime ministerial trajectory three times in eighteen months. Against that backdrop, Tate & Lyle confirmed it is considering a £2.7 billion offer from Illinois-based Ingredion, the latest in a growing roster of UK-listed mid-caps now treated as discount inventory by American strategic buyers.
For European investors the conclusion is structural. The UK’s combination of weakened sterling, elevated political risk, and a public valuation gap of roughly 35 percent versus US peers has converted London’s listed market into an arbitrage opportunity. American capital is responding accordingly. Britain is no longer competing for listings. It is being asset-stripped through them.
The Tate & Lyle setup
The Ingredion approach is textbook. Tate & Lyle, a 165-year-old British food ingredients business with significant US operations, trades at a forward P/E of 9.8. Ingredion, listed on NYSE with a meaningfully smaller revenue base, trades at 14.2. The valuation gap is the deal. Ingredion pays a 30 percent premium to Tate & Lyle’s pre-bid price and still acquires the business at an accretive multiple. London loses a constituent of the FTSE 250. The US gains a global ingredients platform.
Join The European Business Briefing
New subscribers this quarter are entered into a draw to win a Rolex Submariner. Join 40,000+ founders, investors and executives who read EBM every day.
SubscribeThis is not an isolated transaction. Direct Line, Hargreaves Lansdown, Currys and Wincanton have all been acquired or taken private over the past 18 months. The pipeline of UK mid-caps now treated as in-play is the longest it has been since the immediate post-Brexit period.
Why now: sterling, gilts, Westminster
Three factors are stacking. Sterling has weakened against both the dollar and the euro on persistent UK political risk. Gilt yields have risen on inflation pressure compounded by Iran-driven oil prices and the stagflation environment that Britain entered first among the G7. Westminster, meanwhile, has descended into a Labour leadership contest in everything but name. Burnham’s planned by-election route to Downing Street will take months at minimum, during which fiscal direction remains paralysed.
For American acquirers each of these factors is an input to the same calculation. Cheaper sterling lowers the dollar cost of the bid. Higher gilt yields suggest UK rates remain restrictive longer than US rates. Political paralysis reduces the probability of any meaningful regulatory intervention to block deals.
The compounding from Beijing
The Trump-Xi summit’s failure to deliver an Iran or trade breakthrough has compounded the picture. Brent above $107 sustains UK inflation, sustains UK gilt yields, and sustains the case that the Bank of England cannot ease policy. Xi’s pointed reference to Taiwan during the summit added a fresh fracture line, with the US dollar — already strong on the Warsh Fed setup — extending its rally against every major currency. Sterling is caught in that compound: weak fundamentally, weaker still against an outperforming dollar.
For European institutional investors with UK equity allocations, the implication is whether to sell down ahead of further takeover-driven price discovery, or hold for the premium.
The private market pivot
The deeper trend the Tate & Lyle bid signals is the structural migration of capital from public to private markets. Of roughly 159,000 companies globally generating more than $100 million in annual revenue, only 19,000 are publicly listed. The other 140,000 sit in private equity portfolios, family offices, sovereign wealth allocations and venture funds. SpaceX’s $2 trillion IPO next month is the exception that proves the rule — most growth-stage companies now stay private for far longer, and many never list at all.
For UK retail investors the question is sharper. The London market they have access to is shrinking through both takeovers and de-listings. The private market opportunities being newly opened to retail through evergreen funds and listed private equity vehicles are growing, but at higher complexity and lower liquidity.
Britain is on sale. The buyers are American. The mechanism is the public market itself.
Related Analysis
